Literature DB >> 24057047

Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations.

Xiaoqin Huang1, Fang Zheng, Chang-Guo Zhan.   

Abstract

Homology modeling and molecular dynamics simulations have been carried out to model the detailed structures of the human neonatal Fc receptor (FcRn) binding with the wild-type Fc of human immunoglobulin G1 (IgG1) and its various mutants. Based on the modeled human FcRn-Fc binding structures, it has been proposed that the protein-protein binding interface is composed of three subsites. The first subsite is a hydrophobic core where residue I39 of human Fc can be accommodated very well, and the other two subsites are all composed of critical salt bridges between human FcRn and human Fc. All of the modeled structures and the calculated binding energies are qualitatively consistent with the available experimental data, suggesting that the modeled human FcRn-Fc binding structures are reasonable. The modeled human FcRn-Fc binding structure may be valuable for future rational design of novel mutants of human Fc and Fc-fused therapeutic proteins with a potentially higher binding affinity for human FcRn and, thus, a longer in vivo half-life in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057047      PMCID: PMC3834255          DOI: 10.1039/c3mb70231f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  53 in total

1.  Quantification and modeling of tripartite CD2-, CD58FC chimera (alefacept)-, and CD16-mediated cell adhesion.

Authors:  Michael L Dustin; Toby Starr; Daniel Coombs; Gerard R Majeau; Werner Meier; Paula S Hochman; Adam Douglass; Ron Vale; Byron Goldstein; Adrian Whitty
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

2.  Integrating statistical pair potentials into protein complex prediction.

Authors:  Julian Mintseris; Brian Pierce; Kevin Wiehe; Robert Anderson; Rong Chen; Zhiping Weng
Journal:  Proteins       Date:  2007-11-15

3.  Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.

Authors:  Max Crispin; Thomas A Bowden; Charlotte H Coles; Karl Harlos; A Radu Aricescu; David J Harvey; David I Stuart; E Yvonne Jones
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

4.  Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.

Authors:  Yik Andy Yeung; Maya K Leabman; Jonathan S Marvin; Julia Qiu; Camellia W Adams; Samantha Lien; Melissa A Starovasnik; Henry B Lowman
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  A combination of rescoring and refinement significantly improves protein docking performance.

Authors:  Brian Pierce; Zhiping Weng
Journal:  Proteins       Date:  2008-07

6.  Investigation of the influence of FcRn on the distribution of IgG to the brain.

Authors:  Amit Garg; Joseph P Balthasar
Journal:  AAPS J       Date:  2009-07-28       Impact factor: 4.009

7.  Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells.

Authors:  Nancy A Goebl; Clifford M Babbey; Amita Datta-Mannan; Derrick R Witcher; Victor J Wroblewski; Kenneth W Dunn
Journal:  Mol Biol Cell       Date:  2008-10-08       Impact factor: 4.138

Review 8.  FcRn: the neonatal Fc receptor comes of age.

Authors:  Derry C Roopenian; Shreeram Akilesh
Journal:  Nat Rev Immunol       Date:  2007-08-17       Impact factor: 53.106

9.  Structural characterization of a human Fc fragment engineered for extended serum half-life.

Authors:  Vaheh Oganesyan; Melissa M Damschroder; Robert M Woods; Kimberly E Cook; Herren Wu; William F Dall'acqua
Journal:  Mol Immunol       Date:  2009-02-27       Impact factor: 4.407

10.  Structure of the murine unglycosylated IgG1 Fc fragment.

Authors:  Matthias J Feige; Susanne Nath; Silvia R Catharino; Daniel Weinfurtner; Stefan Steinbacher; Johannes Buchner
Journal:  J Mol Biol       Date:  2009-06-24       Impact factor: 5.469

View more
  3 in total

1.  Structural characterization of the Man5 glycoform of human IgG3 Fc.

Authors:  Ishan S Shah; Scott Lovell; Nurjahan Mehzabeen; Kevin P Battaile; Thomas J Tolbert
Journal:  Mol Immunol       Date:  2017-10-12       Impact factor: 4.407

Review 2.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

3.  Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation.

Authors:  Chul Ho Jang; Yu Lan Piao; Xiaoqin Huang; Eun Jeong Yoon; So Hee Park; Kyoung Lee; Chang-Guo Zhan; Hoon Cho
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.